FiercePharma12d
FDA warning letter reveals quality control, data integrity issues at Viatris plant in India
In a warning letter posted online late last month, the FDA scolded Viatris over a range of production slights at the ...
India's cosmetic surgery market set to hit $11.5 billion by 2030: Report
India's cosmetic surgery market is projected to reach $11.5 billion (nearly Rs 1 lakh crore) by 2030 due to a surge in ...
C&EN5d
Indian drug services companies pull in cash
Aragen, based in Hyderabad, says it will use the funds to boost manufacturing capacity for newer treatment modalities, such ...
FDA Pushes to Improve Blood Oxygen Monitor Accuracy Across Skin Tones
The FDA's draft recommendations for pulse oximeters aims to include clinical studies involving at least 150 participants with ...
India West12d
FDA Restricts Imports Of Drug Products Made In Indore For Violations
Viatris, formed through the merger of Mylan and Pfizer’s off-patent drug business, operates four manufacturing sites in India that produce a wide range of therapeutic products, including ...
India TV1d
FDA bans use of Red No. 3 from food, medicine citing cancer risks
The Food and Drug Administration said that it is banning the use of Red No. 3. It is a synthetic dye that is used in food, drinks and medicine to give it a bright red cherry colour. FDA has linked ...
Business Wire1d
FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.
“The FDA’s decision recognizes the role that ZYN can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products.” The FDA’s ...